Aspire BioPharma Inc. — Form C-AR (Regulation Crowdfunding)
Aspire BioPharma Inc. of Humacao, PR filed a Form C-AR (Regulation Crowdfunding) with the SEC on 2024-04-26.
Offering
- Filed: 2024-04-26
- Form: C-AR
- Accession: 0001493152-24-016259
Issuer
- CIK: 0001995528
- Website: https://aspirebiolabs.com
- Legal status: Corporation
- Organized in: PR
- Incorporated: 2021-09-27
- Address: 194 Candelaro Drive, Humacao, PR, 00791
- Employees: 0
Financials (as filed)
- Total assets (most recent): $5.0M
- Cash (most recent): $11K
- Net income (most recent): $-359K
- Net income (prior): $-597K
- Short-term debt: $652K
- Long-term debt: $3.9M
People (3)
| Name | Role | Location |
|---|
| Stephen Quesenberry | General Counsel and Corporate Secretary | salem, UT |
| Ernest J. Scheidemann | Chief Financial Officer | Humacao, PR |
| Kraig T. Higginson | Chief Executive Officer & Chairman of the Board | Humacao, PR |
Reg CF filing history (3)
More